These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 29458193

  • 1. Attenuation of neuro-inflammation improves survival and neurodegeneration in a mouse model of severe neonatal hyperbilirubinemia.
    Vodret S, Bortolussi G, Iaconcig A, Martinelli E, Tiribelli C, Muro AF.
    Brain Behav Immun; 2018 May; 70():166-178. PubMed ID: 29458193
    [Abstract] [Full Text] [Related]

  • 2. Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1 -/- mouse model.
    Vodret S, Bortolussi G, Jašprová J, Vitek L, Muro AF.
    J Neuroinflammation; 2017 Mar 24; 14(1):64. PubMed ID: 28340583
    [Abstract] [Full Text] [Related]

  • 3. Modulation of bilirubin neurotoxicity by the Abcb1 transporter in the Ugt1-/- lethal mouse model of neonatal hyperbilirubinemia.
    Bockor L, Bortolussi G, Vodret S, Iaconcig A, Jašprová J, Zelenka J, Vitek L, Tiribelli C, Muro AF.
    Hum Mol Genet; 2017 Jan 01; 26(1):145-157. PubMed ID: 28025333
    [Abstract] [Full Text] [Related]

  • 4. Albumin administration prevents neurological damage and death in a mouse model of severe neonatal hyperbilirubinemia.
    Vodret S, Bortolussi G, Schreuder AB, Jašprová J, Vitek L, Verkade HJ, Muro AF.
    Sci Rep; 2015 Nov 06; 5():16203. PubMed ID: 26541892
    [Abstract] [Full Text] [Related]

  • 5. Neuroinflammation and ER-stress are key mechanisms of acute bilirubin toxicity and hearing loss in a mouse model.
    Schiavon E, Smalley JL, Newton S, Greig NH, Forsythe ID.
    PLoS One; 2018 Nov 06; 13(8):e0201022. PubMed ID: 30106954
    [Abstract] [Full Text] [Related]

  • 6. Contribution of inflammatory processes to nerve cell toxicity by bilirubin and efficacy of potential therapeutic agents.
    Fernandes A, Brites D.
    Curr Pharm Des; 2009 Nov 06; 15(25):2915-26. PubMed ID: 19754368
    [Abstract] [Full Text] [Related]

  • 7. Minocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemia-induced cerebellar hypoplasia in the Gunn rat.
    Lin S, Wei X, Bales KR, Paul AB, Ma Z, Yan G, Paul SM, Du Y.
    Eur J Neurosci; 2005 Jul 06; 22(1):21-7. PubMed ID: 16029192
    [Abstract] [Full Text] [Related]

  • 8. Neonatal Hyperbilirubinemia: Evaluation and Treatment.
    Par EJ, Hughes CA, DeRico P.
    Am Fam Physician; 2023 May 06; 107(5):525-534. PubMed ID: 37192079
    [Abstract] [Full Text] [Related]

  • 9. Minocycline blocks acute bilirubin-induced neurological dysfunction in jaundiced Gunn rats.
    Geiger AS, Rice AC, Shapiro SM.
    Neonatology; 2007 May 06; 92(4):219-26. PubMed ID: 17556840
    [Abstract] [Full Text] [Related]

  • 10. Impairment of enzymatic antioxidant defenses is associated with bilirubin-induced neuronal cell death in the cerebellum of Ugt1 KO mice.
    Bortolussi G, Codarin E, Antoniali G, Vascotto C, Vodret S, Arena S, Cesaratto L, Scaloni A, Tell G, Muro AF.
    Cell Death Dis; 2015 May 07; 6(5):e1739. PubMed ID: 25950469
    [Abstract] [Full Text] [Related]

  • 11. Trends in hospitalizations of newborns with hyperbilirubinemia and kernicterus in United States: an epidemiological study.
    Vidavalur R, Devapatla S.
    J Matern Fetal Neonatal Med; 2022 Dec 07; 35(25):7701-7706. PubMed ID: 34470114
    [Abstract] [Full Text] [Related]

  • 12. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns.
    Wennberg RP, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM.
    Pediatrics; 2006 Feb 07; 117(2):474-85. PubMed ID: 16452368
    [Abstract] [Full Text] [Related]

  • 13. Age-dependent pattern of cerebellar susceptibility to bilirubin neurotoxicity in vivo in mice.
    Bortolussi G, Baj G, Vodret S, Viviani G, Bittolo T, Muro AF.
    Dis Model Mech; 2014 Sep 07; 7(9):1057-68. PubMed ID: 25062689
    [Abstract] [Full Text] [Related]

  • 14. Rates of Extreme Neonatal Hyperbilirubinemia and Kernicterus in Children and Adherence to National Guidelines for Screening, Diagnosis, and Treatment in Sweden.
    Alkén J, Håkansson S, Ekéus C, Gustafson P, Norman M.
    JAMA Netw Open; 2019 Mar 01; 2(3):e190858. PubMed ID: 30901042
    [Abstract] [Full Text] [Related]

  • 15. Curcumin Prevents Cerebellar Hypoplasia and Restores the Behavior in Hyperbilirubinemic Gunn Rat by a Pleiotropic Effect on the Molecular Effectors of Brain Damage.
    Gazzin S, Dal Ben M, Montrone M, Jayanti S, Lorenzon A, Bramante A, Bottin C, Moretti R, Tiribelli C.
    Int J Mol Sci; 2020 Dec 30; 22(1):. PubMed ID: 33396688
    [Abstract] [Full Text] [Related]

  • 16. Strategies for neonatal hyperbilirubinemia: a literature review.
    Wells C, Ahmed A, Musser A.
    MCN Am J Matern Child Nurs; 2013 Dec 30; 38(6):377-82;quiz 383-4. PubMed ID: 24145492
    [Abstract] [Full Text] [Related]

  • 17. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates.
    Suresh GK, Martin CL, Soll RF.
    Cochrane Database Syst Rev; 2003 Dec 30; (2):CD004207. PubMed ID: 12804504
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological therapies for unconjugated hyperbilirubinemia.
    Cuperus FJ, Hafkamp AM, Hulzebos CV, Verkade HJ.
    Curr Pharm Des; 2009 Dec 30; 15(25):2927-38. PubMed ID: 19754369
    [Abstract] [Full Text] [Related]

  • 19. Glucose-6-Phosphate Dehydrogenase Deficiency and the Need for a Novel Treatment to Prevent Kernicterus.
    Cunningham AD, Hwang S, Mochly-Rosen D.
    Clin Perinatol; 2016 Jun 30; 43(2):341-54. PubMed ID: 27235212
    [Abstract] [Full Text] [Related]

  • 20. Forgoing Exchange Transfusion in Neonatal Hyperbilirubinemia: A Single-Center Retrospective Cohort Study.
    Ouerradi N, Ayyad A, Messaoudi S, Amrani R.
    Cureus; 2024 Mar 30; 16(3):e56749. PubMed ID: 38650795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.